Effects of oral and transdermal 17β-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women

This publication has 22 references indexed in Scilit:

• Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up
  BJOG: An International Journal of Obstetrics and Gynaecology, 1997
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
  JAMA, 1995
• The effects of the menopause on insulin sensitivity, secretion and elimination in non‐obese, healthy women
  European Journal of Clinical Investigation, 1993
• Influence of age and menopause on serum lipids and lipoproteins in healthy women
  Atherosclerosis, 1993
• A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus
  Annals of Epidemiology, 1992
• Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Insulin and Atheroma: 20-Yr Perspective
  Diabetes Care, 1990
• Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics
  Diabetes, 1987
• Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog
  Diabetes, 1980
• Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen
  Journal of Clinical Pathology, 1969